| Financial Year |
March 31 2023 |
| Monetary Funds |
31,843,260,115.00 |
| Held-for-trading Financial Assets |
15,640,000.00 |
| Notes Receivable |
37,143,311.00 |
| Accounts Receivable |
507,271,410.00 |
| Advances to Suppliers |
2,600,238,088.00 |
| Other Receivables |
42,129,963,109.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
200,946,552,654.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,484,049,149.00 |
| Total Current Assets |
298,564,117,836.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
24,895,907,681.00 |
| Investment Properties |
117,079,919,599.00 |
| Fixed Assetes |
2,054,397,758.00 |
| Under-construction Projects |
1,647,255,329.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,407,680,571.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
66,560,658.00 |
| Deferred Income Tax Assets |
7,403,546,851.00 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
155,319,885,955.00 |
| Total Assets |
453,884,003,791.00 |
| Short-Term Loans |
1,533,875,646.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,233,039,928.00 |
| Accounts Payable |
42,132,883,201.00 |
| Accounts Received In Advance |
805,704,550.00 |
| Employee Compensation Payable |
803,852,791.00 |
| Taxes Payable |
10,646,868,827.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
40,148,184,089.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,984,483,097.00 |
| Other Current Liabilities |
15,136,636,868.00 |
| Sub-Total of Current Liabilities |
304,748,891,414.00 |
| Long-term Loans |
33,835,293,414.00 |
| Bonds Payable |
11,888,615,767.00 |
| Long-Term Accounts Payable |
5,161,709,936.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,662,715,843.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
59,186,405,057.00 |
| Total Liabilities |
363,935,296,471.00 |
| Paid-In Capital(Or Share Stock) |
2,255,622,856.00 |
| Capital Surplus |
1,928,952,565.00 |
| Surplus Reserve |
1,130,031,770.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
53,982,957,553.00 |
| Minority Stockholder's Interest |
29,458,006,946.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
60,490,700,374.00 |
| Owner's Equity（Stockholder's Equity） |
89,948,707,320.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
453,884,003,791.00 |
